Top Oncology Companies
169 Oncology companies, sorted by total funding raised.
169
Companies
$15.9B
Combined Funding
2
Funded (Last 60d)
Series B
Top Stage
Indexed tracks 169 Oncology companies that have collectively raised $15.9B in documented funding. The most-funded oncology companies tracked include BeiGene and Avenzo. 2 companies closed a new round in the last 60 days, with Series B being the most common funding stage.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
Novel bicyclic peptides and drug conjugates for cancer
Clinical-stage biopharmaceutical company founded in 2015 developing best-in-class cancer therapeu...
Pathos is an AI-enabled biotechnology company focused on re-engineering drug development.
Biotechnology company focused on the development of antibody-drug conjugates for the treatment of...
Arcellx is a clinical-stage biopharmaceutical company developing novel, adaptive and controllable...
Liquid biopsy cancer screening company integrating multi-cancer early detection into routine medi...
Clinical-stage oncology company developing novel CAR-T cell therapies for hematological malignanc...
Pionyr Immunotherapeutics is developing cancer immunotherapies that target the tumor microenviron...
Clinical-stage biopharma developing dual-action biologics that combine targeted therapy and immun...
Health technology company building oncology-specific electronic health record software and curati...
Clinical-stage biotech engineering best-in-class CAR T-cell therapies to overcome resistance to c...
Clinical-stage biopharma developing and commercializing oncology therapeutics, partnering to glob...
Provides AI and real-world oncology data solutions to life sciences companies, accelerating clini...
Cancer detection company pioneering early cancer screening using AI and biology of cancer origin.
Global oncology company focused on developing therapies to tackle the toughest challenges in canc...
Shanghai-based oncology biotech discovering precision and immuno-oncology therapeutics for cancer...
Commercial-stage biopharmaceutical company developing first-in-class therapeutics for hematologic...
Clinical-stage precision oncology company developing alteration-specific therapeutics for cancer ...
Clinical-stage biopharmaceutical developing novel small molecule radioligands targeting GPCRs for...
Artificial intelligence for drug discovery.
Galvanize Therapeutics is a leader in energy-based medical device technology that impacts biologi...
Clinical-stage biotech developing first-in-class logic-gated CAR-T cell therapies targeting solid...
Precision oncology company developing first-in-class small molecule therapies that reactivate mut...
Top Investors in Oncology
Active investors ranked by total number of investments.
Frequently Asked Questions
How many Oncology companies are tracked on Indexed?
Indexed tracks 169 Oncology companies, sorted by total funding raised.
How much funding have Oncology companies raised in total?
The Oncology companies tracked by Indexed have collectively raised $15.9B in documented funding.
What are the top-funded Oncology companies?
The most-funded Oncology companies tracked include BeiGene, Avenzo, Bicycle Therapeutics.
Who are the top investors in Oncology?
Leading investors active in Oncology include Pfizer Ventures, Amgen, Novartis Venture Fund.
Explore More
Other Industries